{"id":53987,"date":"2023-02-16T11:06:56","date_gmt":"2023-02-16T10:06:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/"},"modified":"2023-02-16T11:06:56","modified_gmt":"2023-02-16T10:06:56","slug":"enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/","title":{"rendered":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer"},"content":{"rendered":"
\n

MILAN–(BUSINESS WIRE)–Enthera Pharmaceuticals<\/a> (\u201cEnthera\u201d), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer. Dr. Canducci brings more than 20 years of experience in translational medicine, clinical research and drug development in inflammatory and autoimmune diseases. Prior to joining Enthera, Dr. Canducci was a senior medical leader at Roche where he led global teams in the clinical development of immunology and infectious disease assets from clinical entry through transitioning to Phase 3. At Enthera, he will be responsible for the clinical development of the company\u2019s lead asset, Ent001, a first-in-class monoclonal antibody (mAb) designed to target the IGFBP3\/TMEM219 axis, a pathway which plays a critical role in both inflammatory bowel disease (IBD) and type 1 diabetes (T1D). Dr. Canducci will also oversee the progress of Enthera\u2019s additional pipeline candidates as the company builds out its proprietary discovery platform for the development of safe and effective, first-in-class biologics for the treatment of autoimmune diseases.\n<\/p>\n

<\/a><\/p>\n

\n\u201cFilippo\u2019s deep scientific and industry experience cultivated across internationally renowned biopharmaceutical companies and research institutes, along with his entrepreneurial mindset, makes him the ideal candidate to guide us as we enter the clinic with Ent001,\u201d said Aled Paton Williams, CEO of Enthera<\/b>. \u201cWe will benefit from his wealth of knowledge, particularly in the field of autoimmune diseases, as we work towards bringing novel therapeutics to underserved patient populations.\u201d\n<\/p>\n

\n\u201cEnthera\u2019s portfolio of first-in-class selective inhibitors based on the novel scientific discovery of the IGFBP3\/TMEM219 pathway, showcases the company\u2019s truly innovative approach to a challenging disease area,\u201d said Filippo Canducci, Chief Medical Officer of Enthera<\/b>. \u201cEnt001 is the only drug of its kind currently in development with the potential to halt and possibly reverse disease progression in both IBD and T1D. I look forward to working with the Enthera team to guide Ent001\u2019s rapid entry into the clinic and to building-out the company\u2019s pipeline.\u201d\n<\/p>\n

\nFilippo Canducci holds an MD from Universit\u00e0 Cattolica del Sacro Cuore in Rome, a PhD from the University of Trieste, and an MBA from SDA Bocconi – School of Management. Dr. Canducci has been published in more than 80 scientific papers in peer-reviewed high impact journals.\n<\/p>\n

\nAbout Enthera Pharmaceuticals<\/b>\n<\/p>\n

\nEnthera Srl is a biotech company developing first-in-class biologics to transform the treatment paradigm for specific autoimmune conditions by re-establishing stem cell capabilities. The Company\u2019s primary target indications are inflammatory bowel disease (IBD) and type 1 diabetes (T1D).\n<\/p>\n

\nEnthera\u2019s pioneering approach capitalizes on the key discovery of the IGFBP3\/TMEM219 pathway, which is involved in stem cell and beta cell apoptosis in the gut and pancreas, respectively.\n<\/p>\n

\nEnthera\u2019s lead program, Ent001, is the only drug in development with the potential to restore the original intestinal structure in IBD and the endogenous pancreatic stem cell compartment in T1D, resulting in restoration of organ function.\n<\/p>\n

\nEnthera is a private company headquartered in Milan, Italy and founded in 2016 by Prof Paolo Fiorina and Dr Francesca D\u2019Addio at BiovelocITA, Italy\u2019s first biotech accelerator. The Company is backed by Sofinnova Partners, AbbVie, JDRF T1D Fund, Roche and a number of private investors. Enthera\u2019s discovery engine and assets are protected by a broad portfolio of patents.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information:<\/b>\n<\/p>\n

\nEnthera Pharmaceuticals<\/b>
Aled Williams, CEO
\n
info@entherapharmaceuticals.com<\/a>\n<\/p>\n

\nTrophic Communications<\/b>
Valeria Fisher or Veronika M\u00e1t\u00e9
\n
+49 175 8041816 or +49 160 90816161
\n
enthera@trophic.eu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MILAN–(BUSINESS WIRE)–Enthera Pharmaceuticals (\u201cEnthera\u201d), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer. Dr. Canducci brings more than 20 years of experience in translational medicine, clinical research and drug development in inflammatory and autoimmune diseases. Prior to joining Enthera, Dr. Canducci … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53987","6":"format-standard","7":"category-industry"},"yoast_head":"\nEnthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MILAN–(BUSINESS WIRE)–Enthera Pharmaceuticals (\u201cEnthera\u201d), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer. Dr. Canducci brings more than 20 years of experience in translational medicine, clinical research and drug development in inflammatory and autoimmune diseases. Prior to joining Enthera, Dr. Canducci ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-02-16T10:06:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer\",\"datePublished\":\"2023-02-16T10:06:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/\"},\"wordCount\":577,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005057\\\/en\\\/1714601\\\/21\\\/Enthera_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/\",\"name\":\"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005057\\\/en\\\/1714601\\\/21\\\/Enthera_Logo.jpg\",\"datePublished\":\"2023-02-16T10:06:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005057\\\/en\\\/1714601\\\/21\\\/Enthera_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230216005057\\\/en\\\/1714601\\\/21\\\/Enthera_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/","og_locale":"en_US","og_type":"article","og_title":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend","og_description":"MILAN–(BUSINESS WIRE)–Enthera Pharmaceuticals (\u201cEnthera\u201d), a biotech company developing first-in-class biologics for selected autoimmune conditions, today announces the appointment of Filippo Canducci MD, PhD as Chief Medical Officer. Dr. Canducci brings more than 20 years of experience in translational medicine, clinical research and drug development in inflammatory and autoimmune diseases. Prior to joining Enthera, Dr. Canducci ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/","og_site_name":"Pharma Trend","article_published_time":"2023-02-16T10:06:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer","datePublished":"2023-02-16T10:06:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/"},"wordCount":577,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/","url":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/","name":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg","datePublished":"2023-02-16T10:06:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230216005057\/en\/1714601\/21\/Enthera_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/enthera-pharmaceuticals-appoints-filippo-canducci-as-chief-medical-officer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Enthera Pharmaceuticals Appoints Filippo Canducci as Chief Medical Officer"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53987","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53987"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53987\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53987"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53987"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53987"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}